Introduction
Programmed cell death, or apoptosis, is a strictly regulated physiological process that plays an important role during development and in tissue homeostasis. The disruption of apoptosis can result in a variety of diseases including cancer, autoimmune diseases, and degenerative disorders [1] . To date, many excellent studies have identified a series of molecules involved in apoptosis, including signal molecules, receptors, enzymes, and gene-regulating proteins. Among them, Bax (Bcl-2-associated X protein) and ARC (apoptosis repressor with caspase recruitment domain) are two important regulatory proteins.
In the intrinsic apoptotic pathway, stress conditions (such as oxidative injuries or UV damage) lead to the activation of cytosolic Bax and its translocation to the mitochondria, which then induces the formation of mitochondrial outer-membrane pore [2] . Subsequently, cytochrome c is released from the mitochondrial intermembrane space into the cytosol where it forms a complex with apoptotic protease activating factor 1 [3 -5] . It recruits and activates procaspase-9, which then activates the executioners, caspase-3 and caspase-7, to cause apoptosis [6, 7] .
In 1998, the human ARC was identified as an endogenous inhibitor of apoptosis [8] . On one hand, ARC can suppress DISC (death-inducing signal complex) formation by binding to Fas, FADD, and procaspase-8; on the other hand, the interaction of ARC with Bax inhibits Bax translocation to mitochondria. Therefore, ARC is a protein that can antagonize both the extrinsic and intrinsic apoptotic pathways [9, 10] .
The recently identified Kazrin protein is highly conserved. In mammals, there are four alternative Kazrin transcripts, encoding three proteins with different N-termini (Kazrins C and D have identical amino acid sequences). Kazrin is not only a novel component of desmosomes that binds the cornified envelope precursor periplakin, but it also undergoes a dynamic spatial reconfiguration at critical developmental transitions in mouse eggs and embryos. Moreover, Kazrin is required for axial elongation and epidermal integrity in Xenopus tropicalis. Kazrin isoforms predominantly localize at the apical plasma membrane, with some signal in the cytoplasm and in the nucleus. To date, Kazrin has been found in a variety of different tissues, and it has been shown to co-localize with three independent proteins: periplakin, desmoplakin, and ARC. These proteins play roles in cell-cell junctions, signal transduction and apoptosis [11] [12] [13] [14] . It is possible that Kazrin may also be involved in ARC-mediated apoptotic processes.
In our study, we found a new splice isoform of Kazrin (named Kazrin F), which differs from the Kazrins A, B, C, D, and E isoforms identified previously. Following knockdown of Kazrin F by siRNA, cells rapidly underwent apoptosis. Kazrin F binds to and co-localizes with both ARC and Bax. The results suggested that Kazrin might be a new regulator of apoptosis.
Materials and Methods

Reagents
Kazrin antibody, anti-tubulin, secondary horseradish peroxidase-conjugated anti-rabbit and anti-mouse antibodies were purchased from SaierBio (Tianjin, China). Anti-Flag antibody was purchased from Invitrogen (Carlsbad, USA). Lipofectamine 2000 was purchased from Invitrogen. MTT was purchased from Sigma (St. Louis, USA). All other reagents were from Promega (Madison, USA) or TaKaRa (Dalian, China).
Cell culture U373MG and HEK293 cells were preserved in the Tianjin Life Science Research Center of Tianjin Medical University (Tianjin, China) and were maintained in MEMa supplemented with 10% fetal bovine serum with 100 U/ml penicillin and 100 mg/ml streptomycin, in a 378C incubator with 5% CO 2 .
Cloning of Kazrin F The primer for 5 0 -rapid amplification of cDNA end (RACE) was: 5 0 -GGAGCGCGAGCTGCTTATC-3 0 , which is complementary to nucleotide position 240-219 of Kazrin A. The 5 0 -RACE was performed using mRNA from U373MG cells using Smart RACE kit (Clontech, Mountain View, USA). The resultant cDNA fragment was collected from agarose gel, cloned into the pGEM-T vector (Promega), and sequenced by the Augct Company (Beijing, China Tris-HCl, and 150 mM NaCl) containing protease inhibitors and phenylmethanesulfonyl fluoride at 48C. The lysate was centrifuged at 11,000 g for 10 min at 48C. The supernatant was transferred to a new tube and incubated with anti-Flag antibody overnight at 48C on a rotary mixer (1:400). Then, agarose beads were added to the complexes and incubated on a rocker for 2 h at 48C, followed by four washes with cold wash buffer (0.05% NP-40, 50 mM Tris-HCl, and 150 mM NaCl), and were resuspended in lysis buffer. The final precipitate was boiled in sample buffer before loading on an SDS-PAGE gel.
Western blot analysis
Cells were washed twice in PBS ( phosphate-buffered saline), then were directly lysed with radio immunoprecipitation assay (RIPA) buffer (1% NP-40, 1 mM TrisHCl, 1 mM MgCl 2 , and 0.1% SDS) containing protease inhibitors for 20-30 min at 48C and were repeatedly blown with a sample injector 20-30 times. The lysate was centrifuged at 11,000 g for 10 min at 48C.The supernatant was heat denatured and placed on ice for 5 min. Protein was loaded onto 10 or 12% Tris -glycine SDS-PAGE gel and separated at 80 -120 V for 1.5-2 h. The protein was transferred to a nitrocellulose membrane and blocked with 5% milk in TBST buffer. ARC and Bax were detected with an anti-Flag antibody (1:2000). Kazrin F was detected with anti-Kazrin (1:500). An antitubulin antibody (1:1000) or anti-GAPDH (1:1000) was used as a control for the equal loading of samples.
Immunofluorescence and imaging
The transfected pcDNA3/Flag-ARC or Bax U373MG cells were fixed in 4% paraformaldehyde for 30 min at 48C. Cells were washed three times with PBS, followed by permeabilization with 0.5% Triton X-100 for 2-3 min. After washing three times with PBS, cells were incubated with PBS containing 10% donkey serum for 2 h. Cells were incubated with a mixture of anti-Kazrin (rabbit anti-human) (1:20) and anti-Flag (murine monoclonal) (1:50) antibodies overnight at 48C. The following day, cells were incubated with the mixture of rhodamine (TRITC) or fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit (1:200) or mouse secondary antibodies (1:200) (Jackson ImmunoResearch, West Grove, USA) for 1 h at 48C. In the final step, cells were moved directly from secondary antibody into a DAPI solution for 5 min and were sealed with coverslips. Images were acquired using a Nikon fluorescence microscope (Tokyo, Japan).
MTT assay
Cells were plated in a 96-well plate and were incubated at 378C for at least 12 h. The cells were transfected with the pSilencer/Kazrin-siRNA or pSilencer/vector. After 24 h, 20 ml of MTT was added to each well, and the cells were incubated at 378C for 4 h. Then, the medium was removed and 100 ml of DMSO was added. The absorbance at 570 nm was detected using a mQuant Universal Microplate Spectrophotometer (Biotek Instrument, Winooski, USA) after the precipitated formazan had dissolved.
Apoptosis assessment
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assays were used to detect apoptosis in U373MG cells. U373MG cells were transfected with pSilencer/Kazrin-siRNA or pSilencer/vector. After 24 h, cell apoptosis was quantified using a commercially available kit (DeadEND TM Fluorometric TUNEL System; Promega) according to the product specifications. Nuclear staining with the chromatin dye DAPI was performed. Apoptosis was observed through a Nikon fluorescence microscope.
Measurement of caspase-3 protease activity
After U373MG cells were transfected with pSilencer/ Kazrin-siRNA or pSilencer/vector 24 h, caspase-3 protease activity was measured using the caspase-3 cellular activity assay kit (GENMED, Shanghai, China) according to the manufacture's instruction and read plate absorbance at 405 nm in a microplate reader.
Statistical analysis
Data are expressed as the mean + SEM. The significant difference between values was analyzed by two-independent t-tests for each time point or experiment, and triplicate or quadruplicate samples were analyzed. Statistical significance was set as P , 0.05.
Results
Kazrin F is a new Kazrin variant and predominant isoform in U373MG cells Using a pair of primers that are complementary to the coding sequence region of Kazrin A and mRNA from Kazrin F is involved in apoptosis U373MG cells (a human glioma cell line), we performed 5 0 -RACE, and retrieved a 0.7-kb fragment. The sequence analysis showed that the fragment is different from Kazrins A, B, C, D and E, and it contains an extended ORF and as well as an additional 97 aa with an initial codon from the 5 0 -end of the Kazrin A coding region (Fig. 1) . To determine the entire sequence of the candidate Kazrin, RT-PCR was done using a reverse primer that is complementary to the 3 0 -end sequence of Kazrin A and a forward primer that is from the 5 0 -end sequence of the 0.7-kb fragment. A 1.9-kb fragment was obtained and cloned. This new variant of Kazrin, Kazrin F, encoded a protein of 518 aa with a unique 97 aa at the N-terminus.
Kazrin antibody was used to determine whether Kazrin F is the predominant isoform of Kazrin in U373MG cells [ Fig. 2(A) ]. We observed a very strong 62 kDa band by western blot analysis, which we also detected with both the Kazrin antibody and the Flag antibody after transfecting U373MG cells with pcDNA3/ Flag-Kazrin F [the flag tag is 3 Â flag, which adds about 4 kDa, as shown in Fig. 2(B) ].
The Kazrin-specific psilencer/Kazrin-siRNA effectively reduced the expression of Kazrin F in U373MG cells To knockdown Kazrin F by specific siRNA for functional studies, we made a construct targeting Kazrin F by inserting the synthetic cDNA fragment encoding hairpin structure siRNA into the pSilencer vector. The expression level of Kazrin F in U373MG cells transfected with the pSilencer/Kazrin-siRNA was decreased compared with the control vector. Fig. 2(C) indicated that, 48 h after transfection with the pSilencer/ Kazrin-siRNA, the Kazrin F expression level was reduced nearly 50% compared with the control vector.
We also made a mutant Kazrin F vector, pcDNA3/ Flag-Kazrin F-m, in which the binding site of 
Kazrin F is involved in apoptosis
Kazrin-siRNA was mutated, but the amino acid sequences were not changed. Forty-eight hours after co-transfecting HEK293 cells with pcDNA3/Flag-Kazrin F-m, pcDNA3/Flag-Kazrin F and pSilencer/ Kazrin-siRNA or pSilencer/vector, the expression levels of Kazrin F/Kazrin F-m were analyzed by western blot analysis. As shown in Fig. 2(D) , the Kazrin F protein levels in the pcDNA3/Flag-Kazrin F and pSilencer/ Kazrin-siRNA groups were dramatically lower than those in the pcDNA3/Flag-Kazrin F-m and pSilencer/ Kazrin-siRNA groups, reduced by nearly 90%. These results demonstrated that Kazrin-siRNA could specifically target Kazrin F.
Knockdown of endogenous Kazrin F by psilencer/ Kazrin-siRNA leads to apoptosis in U373MG cells and stimulates caspase-3 activity To explore the role of Kazrin F on cell growth, we transfected pSilencer/Kazrin-siRNA into U373MG cells, and found that the cells died quickly. The knockdown of endogenous Kazrin in U373MG cells led to a decrease in cell viability by MTT assay [ Fig. 3(A) ], and a TUNEL assay showed that the cells underwent apoptosis 24 h after transfection with the knockdown construct [ Fig. 3(B) ]. This effect was dose dependent in regards to siRNA expression. Cell viability was not significantly affected at 0.1 mg/well in 96-well plates, but it was 
reduced by 40% at 0.4 mg/well compared with the control group. Moreover, there was a dramatic increase in the number of apoptotic cells when the expression of Kazrin-siRNA was increased compared with the control cells. These results indicated that Kazrin F might play an important role in cell apoptosis.
To determine whether expression of Kazrin F-m (with the mutation in the siRNA binding site) attenuated apoptosis induction by Kazrin-siRNA, we established a U373MG cell line (K-mut/U373MG) stably expressing the mutant Kazrin F [ Fig. 3(C) ]. Then, we measured cell viability in K-mut/U373MG cells after transfection with pSilencer/Kazrin-siRNA. We observed significant changes in cell viability for K-mut/U373MG cells compared with the control cells [ Fig. 3(D) ]. These results demonstrated that knockdown of Kazrin F can cause apoptosis in U373MG cells.
In apoptosis pathway, caspase-3 is a key component. To determine whether apoptosis caused by knockdown of endogenous Kazrin F utilizes the caspase-3 signaling pathway, cell extracts from U373MG cells transfected pSilencer/Kazrin-siRNA or control plasmids were analyzed for caspase-3 activity. Caspase-3 activity was dominantly increased in transfected Kazrin-siRNA group A double asterisk (**) denotes P , 0.05. (E) Twenty-four hours after U373MG cells were transiently transfected with pSilencer/Kazrin-siRNA or pSilencer/vector (con), caspase-3 enzymatic activity was tested. The results shown are representative of three independent experiments; the histograms represent average, and error bars represent standard deviation of the means. A double asterisk (**) denotes P , 0.05.
compared with the control group [ Fig. 3(E) ]. Results suggested that the apoptosis caused by knockdown of Kazrin F could activate apoptosis effector caspase-3.
Kazrin F interacts with Bax and ARC
The induction of apoptosis that occurred in U373MG cells upon knockdown of Kazrin F suggested that Kazrin F was required to regulate cell apoptosis. It had been shown that ARC interacted with Kazrin by yeast twohybrid screen and that ARC also directly bound to Bax by co-immunoprecipitation [9, 10, 14] . Based on these observations, we speculated that Kazrin F might regulate apoptosis by interacting with ARC and Bax. Therefore, HEK293 cells were co-transfected with the following expression constructs to assay for interactions between these proteins: pcDNA3/Flag-ARC, pcDNA3/Flag-Bax, and pcDNA3/HA-Kazrin F or control vector pcDNA3/ Flag. Cell lysates were made 48 h after transfection for co-immunoprecipitation. As indicated in Fig. 4 , Kazrin F binds to both ARC and Bax.
To further examine the co-localization of Kazrin F with ARC or Bax, immunofluorescence staining was performed. We transiently transfected U373MG cells with pcDNA3/Flag-ARC or pcDNA3/Flag-Bax. Immunofluorescence images indicated that Kazrin F (stained in red) was predominantly cytosolic, especially around the nucleus, and some signal was also observed in the nucleus. Stained in green, transfected Bax localized more or less evenly throughout the cytosol and in the nuclei of U373MG cells [ Fig. 5(A) ]. Stained in green, ARC was highly expressed in the cytoplasm of U373MG cells, which differs from the earlier report that ARC localized to the nuclei of some cancer cells [15] [ Fig. 5(B) ]. Kazrin F partially co-localized with ARC and Bax around nucleus, indicated by the yellow color from the red channel merged with the green channel.
Discussion
Kazrin is highly conserved in mammals. Previous reports showed that the Kazrin has different variants. Kazrin A encodes a protein that is 421 aa in length, and Kazrin B encodes a protein with 415 aa. Kazrins A and B have an identical 348 aa at the C-terminus. Kazrins C and D encode a same protein that is 327 aa, which is identical to the C-terminal 327 aa of Kazrin A. Kazrin E has 775 aa, and it shares an identical 407 aa in the N-terminus with Kazrin A. Kazrins A, B, and C have similar subcellular distributions, and they function as novel components in cell -cell junctions. The splice variants of Kazrins are differentially expressed in varieties of cells [11] . We were interested in whether new Kazrin variants exist in nervous system cells. To address the question, we performed a 5 0 -RACE using mRNA from the human glioma cell line U373MG with a primer designed from the N-terminus of Kazrin A as a template. Using this technique, we cloned a new variant of Kazrin. It encodes 518 aa with a 400-bp 5 0 UTR that is different from the 5 0 UTR of Kazrin A. Kazrin F has 97 aa at N-terminus that differ from other Kazrin variants; the other 421 aa are identical to Kazrin A. Kazrins A, B, and C/D were recognized as bands between 37 and 47 kDa by western blot analysis [11] , whereas our cloned variant, Kazrin F, ran at about 62 kDa in U373MG cell lysates. Moreover, our results indicate that Kazrin F is the predominant isoform in U373MG cells by western blot. Kazrin F is localized around the nucleus, which is different from the localization of other Kazrins near cell junctions and the membrane. These results suggested that the function of Kazrin F might be different from other Kazrins. 
Kazrin F is involved in apoptosis
To study the function of Kazrin F, we knocked down its expression in U373MG cells with a plasmid expressing siRNA (hair-pin structure) that targets Kazrin F, and we found that inhibition of Kazrin F expression by siRNA induces apoptosis and caspase-3 activity. In summary, the levels of Kazrin F in cells are very critical in determining cell fate, as evidenced by our inability to establish a stable cell line with reduced expression of Kazrin F. Since a reduction in Kazrin F will initiate a death signal, it might be a pivotal checkpoint protein or a switch determining life or death in the complicated network of apoptosis. It is likely to be required both for inducing apoptosis and for prolonging cell survival by directly affecting ARC, Bax, caspase-3, and possibly other important proteins.
ARC is a CARD protein that attenuates death receptor-induced apoptosis by selectively interacting with caspase-2, caspase-8, FADD, and Fas [8, 9, 16] . ARC can also prevent caspase-independent events such as hypoxia-induced cytochrome c release and hydrogen peroxide-induced necrotic cell death [17] [18] [19] . A previous study showed that Kazrin bound ARC in yeast-two hybrid screen [14] . Based on these data, we propose that Kazrin F may protect cells from apoptosis by interaction with ARC. To validate the interaction of Kazrin F and ARC, Co-IP experiments and immunofluorescence staining were performed. We observed subcellular co-localization of these proteins and found that Kazrin F can bind to ARC. According to these results, a possible model explaining the function of Kazrin F in regulation of apoptosis by ARC is that Kazrin F might be a key component of the DISC by binding ARC. When it is knocked-down, activated Fas and FADD trigger the executioners, caspase-3, to cause cell apoptosis.
Bax is a monomeric protein with a predominantly cytoplasmic distribution [20, 21] . During apoptosis, the translocation of Bax to the mitochondrial membrane and its change in conformation are important steps [22, 23] , although the mechanisms underlying its activation and translocation have not been completely elucidated. Many proteins block or promote apoptosis by directly or indirectly affecting Bax activation. For example, Bcl-2 localized in the outer mitochondrial membranes can inhibit Bax translocation from the cytosol to mitochondria [24] . ARC protects against cell death by interfering with Bax activation [10] . p53 is a transcription factor and Kazrin F is involved in apoptosis tumor suppressor protein that induces expression of the Bax gene to promote apoptosis [25] . Here, we present evidence that Kazrin F co-localizes with Bax in cells. Therefore, another possible mechanism to explain the function of Kazrin F in the regulation of apoptosis might be that Kazrin F prevents apoptosis by inhibiting Bax activation or Bax translocation to mitochondria.
So far, several proteins have been found to inhibit apoptosis in mammalian cells. They include inhibitor of apoptosis protein family (IAPs), FLIPs, and antiapoptotic Bcl-2 family members. The mechanism of ARC in regulating apoptosis has been elucidated previously. IAPs inhibit apoptosis by binding specific caspases 3 and 7 and preventing their activity [26, 27] . FLIPs (FLICE inhibitory protein) prevent apoptosis by binding FADD and excluding pro-caspase 8 from DISC [28] . The anti-apoptotic proteins of the Bcl-2 family are localized in the outer mitochondrial membrane and other organelles, and they block apoptosis by binding Bax or inhibiting Bak, by stabilizing mitochondrial integrity and by preventing the release of pro-apoptotic polypeptides [29] [30] [31] . Although all of these proteins inhibit apoptosis, the mechanism by which Kazrin F regulates apoptosis might be different from their mechanisms of action.
Here, we describe the cloning and characterization of a new Kazrin variant, Kazrin F. Its molecular weight and subcellular distribution are different from other isoforms of Kazrin. Kazrin F is distributed primarily around the nucleus, and it is critical to the survival of U373MG cells. Knock-down of Kazrin F by siRNA causes rapid cellular apoptosis. Moreover, Kazrin F binds to and co-localizes with two important apoptotic regulators, ARC and Bax. Our results suggest that Kazrin F plays an important role in apoptosis and cell growth, although its mechanism of action is not yet understood.
